Status:
COMPLETED
Management of Breathlessness with High-flow Nasal Therapy or a Fan
Lead Sponsor:
Tampere University Hospital
Conditions:
Breathlessness
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Airflow directed to the face by a fan is shown to relief breathlessness in palliative care and some studies have suggested High-Flow nasal airflow therapy beneficial as well. However, these two treatm...
Detailed Description
Airflow directed to the face by a fan is shown to relief breathlessness in palliative care and some studies have suggested High-Flow nasal airflow therapy beneficial as well. However, these two treatm...
Eligibility Criteria
Inclusion
- Advanced cancer
- At least 18 years of age
- Breathlessness (At least 3 on a NRS-scale from 0 to 10)
- Capable to understand the study and to give informed consent
- Do not benefit from ICU treatment or resuscitation defined by the physician taking care of the patient
Exclusion
- Insufficient co-operation for the study treatment or to give informed consent
- Oxygen saturation under 88 % on room air
- Need for other device to treat the breathlessness
- The reason of breathlessness can be immediately treated
Key Trial Info
Start Date :
April 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05257850
Start Date
April 26 2022
End Date
December 31 2024
Last Update
January 31 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pirkanmaa Hospice
Tampere, Finland, 33520
2
Tampere University Hospital
Tampere, Finland, 33520